Pyridazinone hybrids: Design, synthesis and evaluation as potential anticonvulsant agents.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Bioorganic chemistry (Print)

• Publication date

  2018-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bioorg.2018.01.001PMID 29334622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design, Synthesis, and Biological Evaluation of 6‐(2‐Amino‐substituted phenyl)‐4‐(substituted phenyl)‐1,2,4‐triazine‐3,5(2H,4H)‐dione Derivatives as Anticonvulsant Agents

  2016cited by this paper
• Pharmaceutical toxicology: designing studies to reduce animal use, while maximizing human translation.

  2013cited by this paper
• Prediction of antihypertensive activity of pyridazinone derivatives through multivariate image analysis applied to QSAR

  2013cited by this paper
• Functional roles of benzothiazole motif in antiepileptic drug research.

  2013cited by this paper
• Design, synthesis and evaluation of N-(substituted benzothiazol-2-yl)amides as anticonvulsant and neuroprotective.

  2012cited by this paper
• γ-Amino butyric acid analogs as novel potent GABA-AT inhibitors: molecular docking, synthesis, and biological evaluation

  2012cited by this paper
• Quinazolino-benzothiazoles: fused pharmacophores as anticonvulsant agents.

  2012cited by this paper
• Design, synthesis and anticonvulsant activities of novel 1-(substituted/unsubstituted benzylidene)-4-(4-(6,8-dibromo-2-(methyl/phenyl)-4-oxoquinazolin-3(4H)-yl)phenyl) semicarbazide derivatives.

  2012cited by this paper
• Triazole incorporated pyridazinones as a new class of antihypertensive agents: design, synthesis and in vivo screening.

  2011cited by this paper
• Synthesis, characterization and antihypertensive activity of pyridazinone derivatives.

  2010cited by this paper
• Discovery of N-(2,6-dimethylphenyl)-substituted semicarbazones as anticonvulsants: hybrid pharmacophore-based design.

  2005cited by this paper
• New anticonvulsant agents.

  2005cited by this paper
• Pyridazine derivatives. Part 33: Sonogashira approaches in the synthesis of 5-substituted-6-phenyl-3(2H)-pyridazinones☆

  2003cited by this paper
• Synthesis and anticonvulsant activity of 4-bromophenyl substituted aryl semicarbazones.

  2000cited by this paper
• Discovery of 6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)- pyridazinebutanoic acid (FK 838): a novel non-xanthine adenosine A1 receptor antagonist with potent diuretic activity.

  1999cited by this paper
• Pyridazine derivatives. XI: Antihypertensive activity of 3-hydrazinocycloheptyl[1,2-c]pyridazine and its hydrazone derivatives.

  1993cited by this paper
• Anticonvulsant activity of 3-oxo-5-substituted benzylidene-6-methyl-(4H)-2-pyridazinylacetamides and 2-pyridazinylacetylhydrazides.

  1990cited by this paper
• Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activit

  1987cited by this paper
• Selective thromboxane synthetase inhibitors and antihypertensive agents. New derivatives of 4-hydrazino-5H-pyridazino[4,5-b]indole, 4-hydrazinopyridazino[4,5-a]indole, and related compounds.

  1987cited by this paper
• Conformational analysis of clinically active anticonvulsant drugs.

  1986cited by this paper
• Antiepileptic Drug Development Program.

  1984cited by this paper
• Antiepileptic Drug Development: II. Anticonvulsant Drug Screening

  1978cited by this paper
• A note on a simple apparatus for detecting neurological deficit in rats and mice.

  1957cited by this paper
• A CONVENIENT METHOD FOR DETERMINING SERUM AND BILE PHOSPHATASE ACTIVITY.

  1934cited by this paper

• Synthesis of Pyridazinone Derivatives Substituted with Methoxy with Phenyl Hydrazine and In Silico Test of Anticancer Activity

  2025cites this paper
• Synthesis of benzothiazole compounds based on 2D graphene oxide membrane nanoreactors.

  2024cites this paper
• Inhibition of Monoamine Oxidases by Pyridazinobenzylpiperidine Derivatives

  2024cites this paper
• Synthesis, Spectroscopic Characterization, Antibacterial Activity, and Computational Studies of Novel Pyridazinone Derivatives

  2023cites this paper
• Synthesis, crystal structure, DFT, Hirshfeld surface analysis, energy framework, docking and molecular dynamic simulations of (E)-4-(4-methylbenzyl)-6-styrylpyridazin-3(2H)-one as anticancer agent

  2023cites this paper
• Diverse pharmacological potential of pyridazine analogs against various diseases.

  2023cites this paper
• Synthesis, Crystal Structure, and Computational Investigations of 2-(2-(4-Fluorophenyl)-2-oxoethyl)-6-methyl-5-(4-methylbenzyl)pyridazin-3(2H)-one as Antiviral Agent

  2023cites this paper
• Synthesis and characterization of new 5,5′-dimethyl- and 5,5′-diphenylhydantoin-conjugated hemorphin derivatives designed as potential anticonvulsant agents

  2022cites this paper
• Recent Insights on Synthetic Methods and Pharmacological Potential in Relation with Structure of Benzothiazoles.

  2022cites this paper
• Synthesis, crystal structure, spectroscopic studies, NBO, AIM and SQMFF calculations of new pyridazinone derivative

  2021cites this paper
• Synthesis, X-ray crystallography, vibrational spectroscopy, thermal and DFT studies of (E)-6-(4-methylstyryl)-4,5-dihydropyridazin-3(2H)-one

  2021cites this paper
• Crystal structure and Hirshfeld surface analysis of 4-(2,6-dichlorobenzyl)-6-[(E)-2-phenylethenyl]pyridazin-3(2H)-one

  2021cites this paper
• Amide as a Potential Pharmacophore for Drug Designing of Novel Anticonvulsant Compounds

  2021cites this paper
• Synthesis, spectroscopy, crystal structure, TGA/DTA study, DFT and molecular docking investigations of (E)-4-(4-methylbenzyl)-6-styrylpyridazin-3(2H)-one

  2020cites this paper
• Polymorphism of 2-(5-benzyl-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)acetic acid with two monoclinic modifications: crystal structures and Hirshfeld surface analyses

  2020cites this paper
• Design, synthesis and docking studies of novel benzopyrone derivatives as anticonvulsants.

  2020cites this paper
• Synthesis, anti-convulsant activity and molecular docking study of novel thiazole pyridazinone hybrid analogues.

  2020cites this paper
• A review on the synthesis and applications of molecules as anticonvulsant drug agent candidates

  2020cites this paper
• Design, synthesis, biological evaluation and in silico studies of novel pyrrolo[3,4-d]pyridazinone derivatives withpromising anti-inflammatory and antioxidant activity.

  2020cites this paper
• Recent advancement in the discovery and development of anti-epileptic biomolecules: An insight into structure activity relationship and Docking.

  2020cites this paper
• Molecular docking of some benzothiazoles derivatives as anticonvulsant agents

  2020cites this paper
• Crystal structure and Hirshfeld surface analysis of ethyl 2-[5-(3-chlorobenzyl)-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl]acetate

  2019cites this paper
• Crystal structure, Hirshfeld surface analysis and DFT studies of 6-[(E)-2-(thiophen-2-yl)ethenyl]-4,5-dihydropyridazin-3(2H)-one

  2019cites this paper
• Crystal structure, Hirshfeld surface analysis and DFT studies of 2-[5-(4-methylbenzyl)-6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl]acetic acid

  2019cites this paper
• Crystal structure and Hirshfeld surface analysis of (E)-6-(4-hydroxy-3-methoxystyryl)-4,5-dihydropyridazin-3(2H)-one

  2019cites this paper
• Crystal structure and Hirshfeld surface analysis of 4-(4-methylbenzyl)-6-phenylpyridazin-3(2H)-one

  2019cites this paper
• Synthesis, in vivo and in silico evaluation of novel 2,3‐dihydroquinazolin‐4(1H)‐one derivatives as potential anticonvulsant agents

  2018cites this paper
• Diverse chemical and biological potentials of various pyridazine and pyridazinone derivatives

  2018cites this paper
• Considerations and Pitfalls in Selecting the Drug Vehicles for Evaluation of New Drug Candidates: Focus on in vivo Pharmaco-Toxicological Assays Based on the Rotarod Performance Test.

  2018cites this paper